APA
Saffari A., Brösse I., Wiemer-Kruel A., Wilken B., Kreuzaler P., Hahn A., Bernhard M. K., van Tilburg C. M., Hoffmann G. F., Gorenflo M., Hethey S., Kaiser O., Kölker S., Wagner R., Witt O., Merkenschlager A., Möckel A., Roser T., Schlump J., Serfling A., Spiegler J., Milde T., Ziegler A. & Syrbe S. (20191125). Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age - a multicenter retrospective study. : Orphanet journal of rare diseases.
Chicago
Saffari Afshin, Brösse Ines, Wiemer-Kruel Adelheid, Wilken Bernd, Kreuzaler Paula, Hahn Andreas, Bernhard Matthias K, van Tilburg Cornelis M, Hoffmann Georg F, Gorenflo Matthias, Hethey Sven, Kaiser Olaf, Kölker Stefan, Wagner Robert, Witt Olaf, Merkenschlager Andreas, Möckel Andreas, Roser Timo, Schlump Jan-Ulrich, Serfling Antje, Spiegler Juliane, Milde Till, Ziegler Andreas and Syrbe Steffen. 20191125. Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age - a multicenter retrospective study. : Orphanet journal of rare diseases.
Harvard
Saffari A., Brösse I., Wiemer-Kruel A., Wilken B., Kreuzaler P., Hahn A., Bernhard M. K., van Tilburg C. M., Hoffmann G. F., Gorenflo M., Hethey S., Kaiser O., Kölker S., Wagner R., Witt O., Merkenschlager A., Möckel A., Roser T., Schlump J., Serfling A., Spiegler J., Milde T., Ziegler A. and Syrbe S. (20191125). Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age - a multicenter retrospective study. : Orphanet journal of rare diseases.
MLA
Saffari Afshin, Brösse Ines, Wiemer-Kruel Adelheid, Wilken Bernd, Kreuzaler Paula, Hahn Andreas, Bernhard Matthias K, van Tilburg Cornelis M, Hoffmann Georg F, Gorenflo Matthias, Hethey Sven, Kaiser Olaf, Kölker Stefan, Wagner Robert, Witt Olaf, Merkenschlager Andreas, Möckel Andreas, Roser Timo, Schlump Jan-Ulrich, Serfling Antje, Spiegler Juliane, Milde Till, Ziegler Andreas and Syrbe Steffen. Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age - a multicenter retrospective study. : Orphanet journal of rare diseases. 20191125.